APO Research
Talk to an analyst

APO RESEARCH · REPORT

Glycosidases

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Glycosidases Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

4 July 2026198 pages

Choose your research edition.

Industry ResearchGlycosidases Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Glycosidases Industry Growth and Trends Forecast to 2032113 pages · $3,450 USDMarket StructureGlobal Glycosidases Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Glycosidases Market Outlook and Growth Opportunities 2026200 pages · $4,250 USDMarket Analysis & ForecastGlobal Glycosidases Market Analysis and Forecast 2026-2032206 pages · $4,950 USD

Market perspective

The global Glycosidases market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Glycosidases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Glycosidases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Glycosidases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Glycosidases is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Glycosidases include Thermo Fisher Scientific, Waters Corporation, Vaupell Holdings, Takara Bio, Sumitomo Bakelite, Shimadzu Analytical, S-BIO, RayBiotech and RandD Systems, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Glycosidases market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Glycosidases and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Glycosidases sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Glycosidases market size, projected growth trends, production technologies, key applications, and end-use industries.

Glycosidases Segment by Company

Thermo Fisher Scientific

Waters Corporation

Vaupell Holdings

Takara Bio

Sumitomo Bakelite

Shimadzu Analytical

S-BIO

RayBiotech

RandD Systems

PerkinElmer

New England Biolabs

Merck Group

Geno Technology

FUJIFILM Wako Pure Chemical Corporation

Danaher

Cambridge Isotope Laboratories

Bruker

Agilent Technologies

Glycosidases Segment by Type

Endoglycosidase

Exoglycosidase

Glycosidases Segment by Application

Academic Research Institutes

Pharmaceutical And Biotechnology Companies

Others

Glycosidases Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Glycosidases market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Glycosidases and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Glycosidases.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Glycosidases market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Glycosidases manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Glycosidases in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Glycosidases in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Glycosidases Industry Trends Table 2. Glycosidases Industry Drivers Table 3. Glycosidases Industry Opportunities and Challenges Table 4. Glycosidases Industry Restraints Table 5. Global Glycosidases Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Glycosidases Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Glycosidases Sales by Manufacturers (k units) & (2021-2026) Table 8. Global Glycosidases Sales Market Share by Manufacturers Table 9. Global Glycosidases Average Sales Price (USD/unit) of Manufacturers (2021-2026) Table 10. Global Glycosidases Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Glycosidases Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Glycosidases Manufacturers, Product Type & Application Table 13. Global Glycosidases Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Glycosidases by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of Endoglycosidase Table 17. Major Manufacturers of Exoglycosidase Table 18. Global Glycosidases Sales by Type 2021 VS 2025 VS 2032 (k units) Table 19. Global Glycosidases Sales by Type (2021-2026) & (k units) Table 20. Global Glycosidases Sales by Type (2027-2032) & (k units) Table 21. Global Glycosidases Sales Market Share by Type (2021-2026) Table 22. Global Glycosidases Sales Market Share by Type (2027-2032) Table 23. Global Glycosidases Revenue by Type 2021 VS 2025 VS 2032 (k units) Table 24. Global Glycosidases Revenue by Type (2021-2026) & (k units) Table 25. Global Glycosidases Revenue by Type (2027-2032) & (k units) Table 26. Global Glycosidases Revenue Market Share by Type (2021-2026) Table 27. Global Glycosidases Revenue Market Share by Type (2027-2032) Table 28. Major Manufacturers of Academic Research Institutes Table 29. Major Manufacturers of Pharmaceutical And Biotechnology Companies Table 30. Major Manufacturers of Others Table 31. Global Glycosidases Sales by Application 2021 VS 2025 VS 2032 (k units) Table 32. Global Glycosidases Sales by Application (2021-2026) & (k units) Table 33. Global Glycosidases Sales by Application (2027-2032) & (k units) Table 34. Global Glycosidases Sales Market Share by Application (2021-2026) Table 35. Global Glycosidases Sales Market Share by Application (2027-2032) Table 36. Global Glycosidases Revenue by Application 2021 VS 2025 VS 2032 (k units) Table 37. Global Glycosidases Revenue by Application (2021-2026) & (k units) Table 38. Global Glycosidases Revenue by Application (2027-2032) & (k units) Table 39. Global Glycosidases Revenue Market Share by Application (2021-2026) Table 40. Global Glycosidases Revenue Market Share by Application (2027-2032) Table 41. Global Glycosidases Sales by Region: 2021 VS 2025 VS 2032 (k units) Table 42. Global Glycosidases Sales by Region (2021-2026) & (k units) Table 43. Global Glycosidases Sales Market Share by Region (2021-2026) Table 44. Global Glycosidases Sales Forecasted by Region (2027-2032) & (k units) Table 45. Global Glycosidases Sales Forecasted Market Share by Region (2027-2032) Table 46. North America Glycosidases Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 47. North America Glycosidases Sales by Country (2021-2026) & (k units) Table 48. North America Glycosidases Sales by Country (2027-2032) & (k units) Table 49. Europe Glycosidases Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 50. Europe Glycosidases Sales by Country (2021-2026) & (k units) Table 51. Europe Glycosidases Sales by Country (2027-2032) & (k units) Table 52. Asia Pacific Glycosidases Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 53. Asia Pacific Glycosidases Sales by Country (2021-2026) & (k units) Table 54. Asia Pacific Glycosidases Sales by Country (2027-2032) & (k units) Table 55. South America, Middle East and Africa Glycosidases Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (k units) Table 56. South America, Middle East and Africa Glycosidases Sales by Country (2021-2026) & (k units) Table 57. South America, Middle East and Africa Glycosidases Sales by Country (2027-2032) & (k units) Table 58. Global Glycosidases Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 59. Global Glycosidases Revenue by Region (2021-2026) & (US$ Million) Table 60. Global Glycosidases Revenue by Region (2027-2032) & (US$ Million) Table 61. Global Glycosidases Revenue Market Share by Region (2021-2026) Table 62. Global Glycosidases Revenue Market Share by Region (2027-2032) Table 63. Thermo Fisher Scientific Company Information Table 64. Thermo Fisher Scientific Business Overview Table 65. Thermo Fisher Scientific Glycosidases Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 66. Thermo Fisher Scientific Glycosidases Product Portfolio Table 67. Thermo Fisher Scientific Recent Development Table 68. Waters Corporation Company Information Table 69. Waters Corporation Business Overview Table 70. Waters Corporation Glycosidases Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 71. Waters Corporation Glycosidases Product Portfolio Table 72. Waters Corporation Recent Development Table 73. Vaupell Holdings Company Information Table 74. Vaupell Holdings Business Overview Table 75. Vaupell Holdings Glycosidases Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 76. Vaupell Holdings Glycosidases Product Portfolio Table 77. Vaupell Holdings Recent Development Table 78. Takara Bio Company Information Table 79. Takara Bio Business Overview Table 80. Takara Bio Glycosidases Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 81. Takara Bio Glycosidases Product Portfolio Table 82. Takara Bio Recent Development Table 83. Sumitomo Bakelite Company Information Table 84. Sumitomo Bakelite Business Overview Table 85. Sumitomo Bakelite Glycosidases Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 86. Sumitomo Bakelite Glycosidases Product Portfolio Table 87. Sumitomo Bakelite Recent Development Table 88. Shimadzu Analytical Company Information Table 89. Shimadzu Analytical Business Overview Table 90. Shimadzu Analytical Glycosidases Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 91. Shimadzu Analytical Glycosidases Product Portfolio Table 92. Shimadzu Analytical Recent Development Table 93. S-BIO Company Information Table 94. S-BIO Business Overview Table 95. S-BIO Glycosidases Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 96. S-BIO Glycosidases Product Portfolio Table 97. S-BIO Recent Development Table 98. RayBiotech Company Information Table 99. RayBiotech Business Overview Table 100. RayBiotech Glycosidases Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 101. RayBiotech Glycosidases Product Portfolio Table 102. RayBiotech Recent Development Table 103. RandD Systems Company Information Table 104. RandD Systems Business Overview Table 105. RandD Systems Glycosidases Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 106. RandD Systems Glycosidases Product Portfolio Table 107. RandD Systems Recent Development Table 108. PerkinElmer Company Information Table 109. PerkinElmer Business Overview Table 110. PerkinElmer Glycosidases Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 111. PerkinElmer Glycosidases Product Portfolio Table 112. PerkinElmer Recent Development Table 113. New England Biolabs Company Information Table 114. New England Biolabs Business Overview Table 115. New England Biolabs Glycosidases Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 116. New England Biolabs Glycosidases Product Portfolio Table 117. New England Biolabs Recent Development Table 118. Merck Group Company Information Table 119. Merck Group Business Overview Table 120. Merck Group Glycosidases Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 121. Merck Group Glycosidases Product Portfolio Table 122. Merck Group Recent Development Table 123. Geno Technology Company Information Table 124. Geno Technology Business Overview Table 125. Geno Technology Glycosidases Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 126. Geno Technology Glycosidases Product Portfolio Table 127. Geno Technology Recent Development Table 128. FUJIFILM Wako Pure Chemical Corporation Company Information Table 129. FUJIFILM Wako Pure Chemical Corporation Business Overview Table 130. FUJIFILM Wako Pure Chemical Corporation Glycosidases Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 131. FUJIFILM Wako Pure Chemical Corporation Glycosidases Product Portfolio Table 132. FUJIFILM Wako Pure Chemical Corporation Recent Development Table 133. Danaher Company Information Table 134. Danaher Business Overview Table 135. Danaher Glycosidases Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 136. Danaher Glycosidases Product Portfolio Table 137. Danaher Recent Development Table 138. Cambridge Isotope Laboratories Company Information Table 139. Cambridge Isotope Laboratories Business Overview Table 140. Cambridge Isotope Laboratories Glycosidases Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 141. Cambridge Isotope Laboratories Glycosidases Product Portfolio Table 142. Cambridge Isotope Laboratories Recent Development Table 143. Bruker Company Information Table 144. Bruker Business Overview Table 145. Bruker Glycosidases Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 146. Bruker Glycosidases Product Portfolio Table 147. Bruker Recent Development Table 148. Agilent Technologies Company Information Table 149. Agilent Technologies Business Overview Table 150. Agilent Technologies Glycosidases Sales (k units), Price (USD/unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 151. Agilent Technologies Glycosidases Product Portfolio Table 152. Agilent Technologies Recent Development Table 153. Key Raw Materials Table 154. Raw Materials Key Suppliers Table 155. Glycosidases Distributors List Table 156. Glycosidases Customers List Table 157. Research Programs/Design for This Report Table 158. Authors List of This Report Table 159. Secondary Sources Table 160. Primary Sources List of Figures Figure 1. Glycosidases Product Image Figure 2. Global Glycosidases Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Glycosidases Market Size (2021-2032) & (US$ Million) Figure 4. Global Glycosidases Sales (2021-2032) & (k units) Figure 5. Global Glycosidases Average Price (USD/unit) & (2021-2032) Figure 6. Global Top 5 and 10 Glycosidases Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. Endoglycosidase Image Figure 9. Exoglycosidase Image Figure 10. Global Glycosidases Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 11. Global Glycosidases Sales Market Share 2021 VS 2025 VS 2032 Figure 12. Global Glycosidases Sales Market Share by Type (2021-2032) Figure 13. Global Glycosidases Revenue by Type (2021 VS 2025 VS 2032) & (k units) Figure 14. Global Glycosidases Revenue Market Share 2021 VS 2025 VS 2032 Figure 15. Global Glycosidases Revenue Market Share by Type (2021-2032) Figure 16. Academic Research Institutes Image Figure 17. Pharmaceutical And Biotechnology Companies Image Figure 18. Others Image Figure 19. Global Glycosidases Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 20. Global Glycosidases Sales Market Share 2021 VS 2025 VS 2032 Figure 21. Global Glycosidases Sales Market Share by Application (2021-2032) Figure 22. Global Glycosidases Revenue by Application (2021 VS 2025 VS 2032) & (k units) Figure 23. Global Glycosidases Revenue Market Share 2021 VS 2025 VS 2032 Figure 24. Global Glycosidases Revenue Market Share by Application (2021-2032) Figure 25. North America Glycosidases Sales and Growth Rate (2021-2032) & (k units) Figure 26. North America Glycosidases Sales Market Share by Country (2021-2032) Figure 27. U.S. Glycosidases Sales and Growth Rate (2021-2032) & (k units) Figure 28. Canada Glycosidases Sales and Growth Rate (2021-2032) & (k units) Figure 29. Mexico Glycosidases Sales and Growth Rate (2021-2032) & (k units) Figure 30. Europe Glycosidases Sales and Growth Rate (2021-2032) & (k units) Figure 31. Europe Glycosidases Sales Market Share by Country (2021-2032) Figure 32. Germany Glycosidases Sales and Growth Rate (2021-2032) & (k units) Figure 33. France Glycosidases Sales and Growth Rate (2021-2032) & (k units) Figure 34. U.K. Glycosidases Sales and Growth Rate (2021-2032) & (k units) Figure 35. Italy Glycosidases Sales and Growth Rate (2021-2032) & (k units) Figure 36. Netherlands Glycosidases Sales and Growth Rate (2021-2032) & (k units) Figure 37. Asia Pacific Glycosidases Sales and Growth Rate (2021-2032) & (k units) Figure 38. Asia Pacific Glycosidases Sales Market Share by Country (2021-2032) Figure 39. China Glycosidases Sales and Growth Rate (2021-2032) & (k units) Figure 40. Japan Glycosidases Sales and Growth Rate (2021-2032) & (k units) Figure 41. South Korea Glycosidases Sales and Growth Rate (2021-2032) & (k units) Figure 42. Southeast Asia Glycosidases Sales and Growth Rate (2021-2032) & (k units) Figure 43. India Glycosidases Sales and Growth Rate (2021-2032) & (k units) Figure 44. Australia Glycosidases Sales and Growth Rate (2021-2032) & (k units) Figure 45. South America, Middle East and Africa Glycosidases Sales and Growth Rate (2021-2032) & (k units) Figure 46. South America, Middle East and Africa Glycosidases Sales Market Share by Country (2021-2032) Figure 47. Brazil Glycosidases Sales and Growth Rate (2021-2032) & (k units) Figure 48. South Africa Glycosidases Sales and Growth Rate (2021-2032) & (k units) Figure 49. Saudi Arabia Glycosidases Sales and Growth Rate (2021-2032) & (k units) Figure 50. Turkey Glycosidases Sales and Growth Rate (2021-2032) & (k units) Figure 51. Argentina Glycosidases Sales and Growth Rate (2021-2032) & (k units) Figure 52. UAE Glycosidases Sales and Growth Rate (2021-2032) & (k units) Figure 53. Egypt Glycosidases Sales and Growth Rate (2021-2032) & (k units) Figure 54. Chile Glycosidases Sales and Growth Rate (2021-2032) & (k units) Figure 55. Global Glycosidases Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Global Glycosidases Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 57. North America Glycosidases Revenue (2021-2032) & (US$ Million) Figure 58. North America Glycosidases Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 59. Europe Glycosidases Revenue (2021-2032) & (US$ Million) Figure 60. Europe Glycosidases Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Asia-Pacific Glycosidases Revenue (2021-2032) & (US$ Million) Figure 62. Asia-Pacific Glycosidases Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. South America, Middle East and Africa Glycosidases Revenue (2021-2032) & (US$ Million) Figure 64. South America, Middle East and Africa Glycosidases Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. Glycosidases Value Chain Figure 66. Manufacturing Cost Structure Figure 67. Glycosidases Production Mode & Process Figure 68. Direct Comparison with Distribution Share Figure 69. Distributors Profiles Figure 70. Years Considered Figure 71. Research Process Figure 72. Key Executives Interviewed

Scope & coverage.

Types
  • Endoglycosidase
  • Exoglycosidase
Applications
  • Academic Research Institutes
  • Pharmaceutical And Biotechnology Companies
  • Others
Companies covered
  • Thermo Fisher Scientific
  • Waters Corporation
  • Vaupell Holdings
  • Takara Bio
  • Sumitomo Bakelite
  • Shimadzu Analytical
  • S-BIO
  • RayBiotech
  • RandD Systems
  • PerkinElmer
  • New England Biolabs
  • Merck Group
  • Geno Technology
  • FUJIFILM Wako Pure Chemical Corporation
  • Danaher
  • Cambridge Isotope Laboratories
  • Bruker
  • Agilent Technologies

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Glycosidases Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Glycosidases Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Glycosidases Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Glycosidases Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Glycosidases Market Dynamics
  1. 2.1 Glycosidases Industry Trends
  2. 2.2 Glycosidases Industry Drivers
  3. 2.3 Glycosidases Industry Opportunities and Challenges
  4. 2.4 Glycosidases Industry Restraints
3 Glycosidases Market by Manufacturers
  1. 3.1 Global Glycosidases Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Glycosidases Sales by Manufacturers (2021-2026)
  3. 3.3 Global Glycosidases Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Glycosidases Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Glycosidases Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Glycosidases Manufacturers, Product Type & Application
  7. 3.7 Global Glycosidases Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Glycosidases Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Glycosidases Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Glycosidases Tier 1, Tier 2, and Tier 3
4 Glycosidases Market by Type
  1. 4.1 Glycosidases Type Introduction
  2. 4.1.1 Endoglycosidase
  3. 4.1.2 Exoglycosidase
  4. 4.2 Global Glycosidases Sales by Type
  5. 4.2.1 Global Glycosidases Sales by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Glycosidases Sales by Type (2021-2032)
  7. 4.2.3 Global Glycosidases Sales Market Share by Type (2021-2032)
  8. 4.3 Global Glycosidases Revenue by Type
  9. 4.3.1 Global Glycosidases Revenue by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Glycosidases Revenue by Type (2021-2032)
  11. 4.3.3 Global Glycosidases Revenue Market Share by Type (2021-2032)
5 Glycosidases Market by Application
  1. 5.1 Glycosidases Application Introduction
  2. 5.1.1 Academic Research Institutes
  3. 5.1.2 Pharmaceutical And Biotechnology Companies
  4. 5.1.3 Others
  5. 5.2 Global Glycosidases Sales by Application
  6. 5.2.1 Global Glycosidases Sales by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Glycosidases Sales by Application (2021-2032)
  8. 5.2.3 Global Glycosidases Sales Market Share by Application (2021-2032)
  9. 5.3 Global Glycosidases Revenue by Application
  10. 5.3.1 Global Glycosidases Revenue by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Glycosidases Revenue by Application (2021-2032)
  12. 5.3.3 Global Glycosidases Revenue Market Share by Application (2021-2032)
6 Global Glycosidases Sales by Region
  1. 6.1 Global Glycosidases Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Glycosidases Sales by Region (2021-2032)
  3. 6.2.1 Global Glycosidases Sales by Region (2021-2026)
  4. 6.2.2 Global Glycosidases Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Glycosidases Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Glycosidases Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Glycosidases Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Glycosidases Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Glycosidases Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Glycosidases Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Glycosidases Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Glycosidases Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Glycosidases Revenue by Region
  1. 7.1 Global Glycosidases Revenue by Region
  2. 7.1.1 Global Glycosidases Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Glycosidases Revenue by Region (2021-2026)
  4. 7.1.3 Global Glycosidases Revenue by Region (2027-2032)
  5. 7.1.4 Global Glycosidases Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Glycosidases Revenue (2021-2032)
  8. 7.2.2 North America Glycosidases Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Glycosidases Revenue (2021-2032)
  11. 7.3.2 Europe Glycosidases Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Glycosidases Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Glycosidases Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Glycosidases Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Glycosidases Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Thermo Fisher Scientific
  2. 8.1.1 Thermo Fisher Scientific Company Information
  3. 8.1.2 Thermo Fisher Scientific Business Overview
  4. 8.1.3 Thermo Fisher Scientific Glycosidases Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Thermo Fisher Scientific Glycosidases Product Portfolio
  6. 8.1.5 Thermo Fisher Scientific Recent Developments
  7. 8.2 Waters Corporation
  8. 8.2.1 Waters Corporation Company Information
  9. 8.2.2 Waters Corporation Business Overview
  10. 8.2.3 Waters Corporation Glycosidases Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Waters Corporation Glycosidases Product Portfolio
  12. 8.2.5 Waters Corporation Recent Developments
  13. 8.3 Vaupell Holdings
  14. 8.3.1 Vaupell Holdings Company Information
  15. 8.3.2 Vaupell Holdings Business Overview
  16. 8.3.3 Vaupell Holdings Glycosidases Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Vaupell Holdings Glycosidases Product Portfolio
  18. 8.3.5 Vaupell Holdings Recent Developments
  19. 8.4 Takara Bio
  20. 8.4.1 Takara Bio Company Information
  21. 8.4.2 Takara Bio Business Overview
  22. 8.4.3 Takara Bio Glycosidases Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Takara Bio Glycosidases Product Portfolio
  24. 8.4.5 Takara Bio Recent Developments
  25. 8.5 Sumitomo Bakelite
  26. 8.5.1 Sumitomo Bakelite Company Information
  27. 8.5.2 Sumitomo Bakelite Business Overview
  28. 8.5.3 Sumitomo Bakelite Glycosidases Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Sumitomo Bakelite Glycosidases Product Portfolio
  30. 8.5.5 Sumitomo Bakelite Recent Developments
  31. 8.6 Shimadzu Analytical
  32. 8.6.1 Shimadzu Analytical Company Information
  33. 8.6.2 Shimadzu Analytical Business Overview
  34. 8.6.3 Shimadzu Analytical Glycosidases Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Shimadzu Analytical Glycosidases Product Portfolio
  36. 8.6.5 Shimadzu Analytical Recent Developments
  37. 8.7 S-BIO
  38. 8.7.1 S-BIO Company Information
  39. 8.7.2 S-BIO Business Overview
  40. 8.7.3 S-BIO Glycosidases Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 S-BIO Glycosidases Product Portfolio
  42. 8.7.5 S-BIO Recent Developments
  43. 8.8 RayBiotech
  44. 8.8.1 RayBiotech Company Information
  45. 8.8.2 RayBiotech Business Overview
  46. 8.8.3 RayBiotech Glycosidases Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 RayBiotech Glycosidases Product Portfolio
  48. 8.8.5 RayBiotech Recent Developments
  49. 8.9 RandD Systems
  50. 8.9.1 RandD Systems Company Information
  51. 8.9.2 RandD Systems Business Overview
  52. 8.9.3 RandD Systems Glycosidases Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 RandD Systems Glycosidases Product Portfolio
  54. 8.9.5 RandD Systems Recent Developments
  55. 8.10 PerkinElmer
  56. 8.10.1 PerkinElmer Company Information
  57. 8.10.2 PerkinElmer Business Overview
  58. 8.10.3 PerkinElmer Glycosidases Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 PerkinElmer Glycosidases Product Portfolio
  60. 8.10.5 PerkinElmer Recent Developments
  61. 8.11 New England Biolabs
  62. 8.11.1 New England Biolabs Company Information
  63. 8.11.2 New England Biolabs Business Overview
  64. 8.11.3 New England Biolabs Glycosidases Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 New England Biolabs Glycosidases Product Portfolio
  66. 8.11.5 New England Biolabs Recent Developments
  67. 8.12 Merck Group
  68. 8.12.1 Merck Group Company Information
  69. 8.12.2 Merck Group Business Overview
  70. 8.12.3 Merck Group Glycosidases Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Merck Group Glycosidases Product Portfolio
  72. 8.12.5 Merck Group Recent Developments
  73. 8.13 Geno Technology
  74. 8.13.1 Geno Technology Company Information
  75. 8.13.2 Geno Technology Business Overview
  76. 8.13.3 Geno Technology Glycosidases Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Geno Technology Glycosidases Product Portfolio
  78. 8.13.5 Geno Technology Recent Developments
  79. 8.14 FUJIFILM Wako Pure Chemical Corporation
  80. 8.14.1 FUJIFILM Wako Pure Chemical Corporation Company Information
  81. 8.14.2 FUJIFILM Wako Pure Chemical Corporation Business Overview
  82. 8.14.3 FUJIFILM Wako Pure Chemical Corporation Glycosidases Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 FUJIFILM Wako Pure Chemical Corporation Glycosidases Product Portfolio
  84. 8.14.5 FUJIFILM Wako Pure Chemical Corporation Recent Developments
  85. 8.15 Danaher
  86. 8.15.1 Danaher Company Information
  87. 8.15.2 Danaher Business Overview
  88. 8.15.3 Danaher Glycosidases Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Danaher Glycosidases Product Portfolio
  90. 8.15.5 Danaher Recent Developments
  91. 8.16 Cambridge Isotope Laboratories
  92. 8.16.1 Cambridge Isotope Laboratories Company Information
  93. 8.16.2 Cambridge Isotope Laboratories Business Overview
  94. 8.16.3 Cambridge Isotope Laboratories Glycosidases Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Cambridge Isotope Laboratories Glycosidases Product Portfolio
  96. 8.16.5 Cambridge Isotope Laboratories Recent Developments
  97. 8.17 Bruker
  98. 8.17.1 Bruker Company Information
  99. 8.17.2 Bruker Business Overview
  100. 8.17.3 Bruker Glycosidases Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Bruker Glycosidases Product Portfolio
  102. 8.17.5 Bruker Recent Developments
  103. 8.18 Agilent Technologies
  104. 8.18.1 Agilent Technologies Company Information
  105. 8.18.2 Agilent Technologies Business Overview
  106. 8.18.3 Agilent Technologies Glycosidases Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Agilent Technologies Glycosidases Product Portfolio
  108. 8.18.5 Agilent Technologies Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Glycosidases Value Chain Analysis
  2. 9.1.1 Glycosidases Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Glycosidases Production Mode & Process
  6. 9.2 Glycosidases Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Glycosidases Distributors
  9. 9.2.3 Glycosidases Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst